Expertise in
10
conditions

Dr. Hugo Quiroz

Ophthalmology
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 
Expertise in
10
conditions
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 

Overview

Hugo Quiroz is an Ophthalmologist in Aurora, Colorado. Dr. Quiroz is highly rated in 10 conditions, according to our data. His top areas of expertise are Retinopathy of Prematurity, Retinal Detachment, Diabetic Retinopathy, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Ophthalmology

Licenses

Ophthalmology in CO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

University of Colorado Hospital
1665 Aurora Ct Fl 2, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
Enrollment Status: Withdrawn
Publish Date: June 05, 2024
Intervention Type: Drug
Study Drug: Bevacizumab
Study Phase: Phase 2/Phase 3
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Enrollment Status: Terminated
Publish Date: June 03, 2024
Intervention Type: Drug
Study Drug: Intravitreal Injection of Bevacizumab
Study Phase: Phase 3
Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)
Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)
Enrollment Status: Terminated
Publish Date: May 31, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Drug, Procedure
Study Drug: Bevacizumab
Study Phase: Phase 3
Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study
Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Procedure, Drug
Study Drug: Intravitreal Injection of Bevacizumab
Study Phase: Phase 2/Phase 3
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Drug, Procedure
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

90 Total Publications

Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.
Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.
Journal: Current therapeutic research, clinical and experimental
Published: December 13, 2024
Similar Doctors
Expertise in
24
conditions
Dr. Alan Palestine
Ophthalmology
Expertise in
24
conditions
Dr. Alan Palestine
Ophthalmology

Office

1675 Aurora Ct, 
Aurora, CO 
 (8.1 miles away)
720-553-2020
Languages Spoken:
English
See accepted insurances

Alan Palestine is an Ophthalmologist in Aurora, Colorado. Dr. Palestine is highly rated in 24 conditions, according to our data. His top areas of expertise are Uveitis, Scleritis, Age-Related Macular Degeneration (ARMD), Cataract Removal, and Vitrectomy.

Expertise in
11
conditions
Dr. Leonard Seibold
Ophthalmology
Expertise in
11
conditions
Dr. Leonard Seibold
Ophthalmology

Office

1675 Aurora Ct, 
Aurora, CO 
 (8.1 miles away)
720-848-5029
Languages Spoken:
English
See accepted insurances

Leonard Seibold is an Ophthalmologist in Aurora, Colorado. Dr. Seibold is highly rated in 11 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.

Expertise in
28
conditions
Dr. Marc Mathias
Ophthalmology
Expertise in
28
conditions
Dr. Marc Mathias
Ophthalmology

Office

1675 Aurora Ct, 
Aurora, CO 
 (8.1 miles away)
720-553-0393
Languages Spoken:
English
See accepted insurances

Marc Mathias is an Ophthalmologist in Aurora, Colorado. Dr. Mathias is highly rated in 28 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Hormone Replacement Therapy (HRT).

Frequently Asked Questions about Dr. Hugo Quiroz

How do I make an appointment with Dr. Hugo Quiroz?

You can book an appointment with Dr. Hugo Quiroz by calling their office at 720-848-0000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Hugo Quiroz a top-rated expert for Vitrectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hugo Quiroz is classified as an Elite expert for Vitrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Hugo Quiroz specialize in?

While Dr. Hugo Quiroz is a Ophthalmology, they have specific expertise in Vitrectomy, Retinopathy of Prematurity, and Retinal Detachment. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Hugo Quiroz participate in research or clinical trials?

Yes. Dr. Hugo Quiroz has published 90 articles and abstracts on conditions like Vitrectomy. You can view a list of Dr. Hugo Quiroz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Quiroz's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile